← Evidence map

ArticleNeurobiology of disease2017

Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice.

Kathryn P MacPherson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

101 papers cite itlatest 60 shown

2017
…
2021
2022
2023
2024
2025
2026
this papercites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 28237313